Cormorant Asset Management, LP Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$1.4T
Holdings
73
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (73 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —PROMETHEUS BIOSCIENCES INC | 1,979,158 | $116.8B | 8.16% | |
| 2 | APLSAPELLIS PHARMACEUTICALS INC | 1,478,000 | $100.9B | 7.06% | |
| 3 | DSGNDESIGN THERAPEUTICS INC | 5,000,000 | $83.6B | 5.84% | |
| 4 | ERASERASCA INC | 10,505,554 | $81.9B | 5.73% | |
| 5 | ACLXARCELLX INC | 3,049,173 | $57.2B | 4.00% | |
| 6 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 6,065,001 | $47.1B | 3.29% | |
| 7 | ALTALTIMMUNE INC | 3,442,863 | $44.0B | 3.07% | |
| 8 | MRTXEURMIRATI THERAPEUTICS INC | 575,000 | $40.2B | 2.81% | |
| 9 | RVMDREVOLUTION MEDICINES INC | 1,995,066 | $39.3B | 2.75% | |
| 10 | AVTEAEROVATE THERAPEUTICS INC | 2,330,691 | $38.6B | 2.70% | |
| 11 | GOSSGOSSAMER BIO INC | 3,198,382 | $38.3B | 2.68% | |
| 12 | TARSTARSUS PHARMACEUTICALS INC | 1,971,422 | $33.8B | 2.36% | |
| 13 | KRTXKARUNA THERAPEUTICS INC | 150,000 | $33.7B | 2.36% | |
| 14 | RNAAVIDITY BIOSCIENCES INC | 2,012,115 | $32.9B | 2.30% | |
| 15 | IMRXIMMUNEERING CORP | 2,286,181 | $32.7B | 2.29% | |
| 16 | BMEABIOMEA FUSION INC | 3,170,872 | $31.0B | 2.17% | |
| 17 | EWTXEDGEWISE THERAPEUTICS INC | 3,051,989 | $30.0B | 2.10% | |
| 18 | —BIOHAVEN PHARMACTL HLDG CO L | 184,894 | $27.9B | 1.95% | |
| 19 | VTYXVENTYX BIOSCIENCES INC | 780,646 | $27.3B | 1.90% | |
| 20 | VRDNVIRIDIAN THERAPEUTICS INC | 1,310,000 | $26.9B | 1.88% | |
| 21 | GLUEMONTE ROSA THERAPEUTICS INC | 2,993,717 | $24.5B | 1.71% | |
| 22 | —GREENLIGHT BIOSCIENCS HLDS P | 10,261,560 | $23.8B | 1.66% | |
| 23 | AXNX*AXONICS INC | 322,240 | $22.7B | 1.59% | |
| 24 | SRPTSAREPTA THERAPEUTICS INC | 200,000 | $22.1B | 1.55% | |
| 25 | COGTCOGENT BIOSCIENCES INC | 1,450,000 | $21.6B | 1.51% | |
| 26 | VERVVERVE THERAPEUTICS INC | 600,000 | $20.6B | 1.44% | |
| 27 | TORCEURADICET BIO INC | 1,400,000 | $19.9B | 1.39% | |
| 28 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,000,000 | $19.1B | 1.34% | |
| 29 | AMLXAMYLYX PHARMACEUTICALS INC | 610,000 | $17.2B | 1.20% | |
| 30 | BCABBIOATLA INC | 2,181,115 | $16.8B | 1.17% | |
| 31 | PLRXPLIANT THERAPEUTICS INC | 782,788 | $16.4B | 1.14% | |
| 32 | —VECTIVBIO HLDG AG | 2,536,617 | $15.2B | 1.06% | |
| 33 | TNGXTANGO THERAPEUTICS INC | 4,116,949 | $14.9B | 1.04% | |
| 34 | BBIOBRIDGEBIO PHARMA INC | 1,469,179 | $14.6B | 1.02% | |
| 35 | CYTKCYTOKINETICS INC | 296,000 | $14.3B | 1.00% | |
| 36 | STOKSTOKE THERAPEUTICS INC | 1,087,807 | $14.0B | 0.98% | |
| 37 | RCKTROCKET PHARMACEUTICALS INC | 868,550 | $13.9B | 0.97% | |
| 38 | —RAIN THERAPEUTICS INC | 2,326,660 | $11.4B | 0.79% | |
| 39 | CATBUSDASTRIA THERAPEUTICS INC | 1,200,000 | $10.8B | 0.76% | |
| 40 | LLYLILLY ELI & CO | 30,000 | $9.7B | 0.68% | |
| 41 | PHVSPHARVARIS N V | 1,207,500 | $9.3B | 0.65% | |
| 42 | OPHTEURIVERIC BIO INC | 500,000 | $9.0B | 0.63% | Put |
| 43 | AVIRATEA PHARMACEUTICALS INC | 1,547,181 | $8.8B | 0.62% | |
| 44 | CNTACENTESSA PHARMACEUTICALS PLC | 1,972,728 | $7.9B | 0.55% | |
| 45 | —LONGBOARD PHARMACEUTICALS IN | 2,118,283 | $7.9B | 0.55% | |
| 46 | GHRSGH RESEARCH PLC | 593,043 | $6.9B | 0.48% | |
| 47 | ALXOALX ONCOLOGY HLDGS INC | 712,079 | $6.8B | 0.48% | |
| 48 | TYRATYRA BIOSCIENCES INC | 743,988 | $6.5B | 0.46% | |
| 49 | PSTXUSDPOSEIDA THERAPEUTICS INC | 1,850,000 | $6.5B | 0.46% | |
| 50 | IDYAIDEAYA BIOSCIENCES INC | 418,320 | $6.2B | 0.44% | |
| 51 | OLMAOLEMA PHARMACEUTICALS INC | 2,082,000 | $5.7B | 0.40% | |
| 52 | VIGLVIGIL NEUROSCIENCE INC | 616,786 | $5.6B | 0.39% | |
| 53 | ASNDASCENDIS PHARMA A/S | 50,000 | $5.2B | 0.36% | |
| 54 | KROSKEROS THERAPEUTICS INC | 100,000 | $3.8B | 0.26% | |
| 55 | ELDNELEDON PHARMACEUTICALS INC | 1,223,500 | $3.4B | 0.24% | |
| 56 | —AKOUOS INC | 394,500 | $2.7B | 0.19% | |
| 57 | —AMBRX BIOPHARMA INC | 2,336,389 | $2.5B | 0.18% | |
| 58 | —TALARIS THERAPEUTICS INC | 900,649 | $2.4B | 0.17% | |
| 59 | —ELEVATION ONCOLOGY INC | 1,952,032 | $2.2B | 0.15% | |
| 60 | YMABUSDY-MABS THERAPEUTICS INC | 150,000 | $2.2B | 0.15% | |
| 61 | —ICOSAVAX INC | 643,825 | $2.0B | 0.14% | |
| 62 | GLTOUSDGALECTO INC | 1,020,238 | $1.9B | 0.13% | |
| 63 | ASNSUSDX4 PHARMACEUTICALS INC | 830,654 | $1.4B | 0.10% | |
| 64 | PYXSPYXIS ONCOLOGY INC | 668,855 | $1.3B | 0.09% | |
| 65 | AUTLAUTOLUS THERAPEUTICS PLC | 392,167 | $839.0M | 0.06% | |
| 66 | CABACABALETTA BIO INC | 1,154,424 | $750.0M | 0.05% | |
| 67 | CMMBCHEMOMAB THERAPEUTICS LTD | 288,169 | $718.0M | 0.05% | |
| 68 | GLSHQGELESIS HLDGS INC | 626,107 | $676.0M | 0.05% | |
| 69 | GRPHGRAPHITE BIO INC | 199,547 | $633.0M | 0.04% | |
| 70 | —HARPOON THERAPEUTICS INC | 540,600 | $524.0M | 0.04% | |
| 71 | BCELATRECA INC | 319,057 | $501.0M | 0.04% | |
| 72 | ORTXUSDORCHARD THERAPEUTICS PLC | 256,649 | $128.0M | 0.01% | |
| 73 | IMV1EURIMV INC | 234,374 | $122.0M | 0.01% |